Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 5:11 AM
Ignite Modification Date: 2025-12-25 @ 5:11 AM
NCT ID: NCT01533727
Eligibility Criteria: Inclusion Criteria: 1. Stage IB-IIIA post-surgery NSCLC patients with histologically confirmed. 2. with an Eastern CooperativeOncology Group performance status of 0 or 1, 3. at least 18 years of age 4. adequate bone marrow reserve and organ function including calculated creatinine clearance 45 mL/min based on the standard Cockcroft and Gault formula 5. patients had fully recovered from its acute effects. Exclusion Criteria: 1. HIV positive 2. autoimmune disease 3. immune deficiency disorder 4. organ transplantation 5. received high dose glucocorticoid or other immune depressant within 4 weeks 6. active clinically serious infections (\> grade 2 NCI-CTC version 3.0) 7. life threatening medical condition
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 70 Years
Study: NCT01533727
Study Brief:
Protocol Section: NCT01533727